Vanda Pharma's Trade Secrets Suit Against FDA Moves Forward
19 Enero 2024 - 3:57PM
Noticias Dow Jones
By Dean Seal
A federal court has denied the government's bid to throw out a
lawsuit from Vanda Pharmaceuticals accusing the Food and Drug
Administration of handing trade secrets to generic drug makers.
Vanda said on Friday that the U.S. Court of Federal Claims
permitted some of its claims against the government to proceed
following oral arguments on a motion to dismiss last week.
The biopharmaceutical company said in its lawsuit filed in May
that the FDA improperly provided confidential details about its
sleep-wake disorder drug Hertlioz and its schizophrenia treatment
Fanapt to generic drug manufacturers while it reviewed Vanda's new
drug applications.
Vanda is seeking compensation and will now engage in discovery
to support its claims, the company said Friday.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 19, 2024 16:42 ET (21:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024